Low 6-thioguanine nucleotide level: Effective in maintaining remission in Chinese patients with Crohn's disease

Rui Feng, Jing Guo, Sheng hong Zhang, Yun Qiu, Bai li Chen, Yao He, Zhi rong Zeng, Shomron Ben-Horin, Min hu Chen, Ren Mao*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Background and Aim: Measuring 6-thioguanine nucleotide (6-TGN) level is useful in optimizing dose of azathioprine (AZA) and monitoring for toxicity. Lower dose of AZA was suggested for maintenance of clinical remission in Asian patients than Caucasian patients with Crohn's disease (CD). However, the optimal 6-TGN threshold required in Asian patients is undetermined. Therefore, the aim of the current study is to explore the optimal 6-TGN threshold required in Asian patients with CD for maintenance of clinical remission. Methods: A retrospective cohort study in a tertiary referral center recruited 252 CD patients. The primary endpoint was disease relapse. The levels of 6-TGN and AZA dose were compared in remission group and relapse group. Remission rate was compared across the increased 6-TGN level and dose range. Results: Patients with 6-TGN range of 0–180.94 pmol/8 × 10 8 red blood cells (RBC) had lower remission rate compared with those with 180.94–255.50 pmol/8 × 10 8 RBC (P = 0.020). Quartile analysis showed that increasing 6-TGN level beyond 180 pmol/8 × 10 8 RBC produced negligible gain in rate of remission. Frequency of adverse events significantly increased in patients with 6-TGN level > 355 pmol/8 × 10 8 RBC (8.0% with 6-TGN > 355 pmol/8 × 10 8 RBC vs 2.7% with 6-TGN < 355 pmol/8 × 10 8 RBC, P = 0.035). Conclusion: Our study suggested that optimal 6-TGN threshold required to maintain clinical remission in Chinese patients was 180–355 pmol/8 × 10 8 RBC.

Original languageEnglish
Pages (from-to)679-685
Number of pages7
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume34
Issue number4
DOIs
StatePublished - Apr 2019
Externally publishedYes

Funding

FundersFunder number
National Natural Science Foundation of China81630018, 81500501, 81600408, 81470821

    Keywords

    • 6-TGN
    • Crohn's disease
    • clinical remission
    • thiopurines

    Fingerprint

    Dive into the research topics of 'Low 6-thioguanine nucleotide level: Effective in maintaining remission in Chinese patients with Crohn's disease'. Together they form a unique fingerprint.

    Cite this